Synthesis of Dihydrohelminthosporic and Allodihydrohelminthosporic Acids and their Plant Growth-regulating Activity

Li-NH₃ reduction of helminthosporic acid gave dihydrohelminthosporic acid (III) and allodihydrohelminthosporic acid (IV). III and IV are the epimers with respect to the carboxyl and III is labil form. The stereochemistry of III and IV is elucidated from the chemical and spectroscopic evidences. III showed a marked plant growth promoting activity but IV did not.     

Beesioside III,a cyclolanostanol xyloside from the rhizomes of Beesia calthaefolia and Souliea vaginata

The chemical constituents of Beesia calthaefolia and Souliea vaginata were examined. From the rhizomes of B. calthaefolia, four new 9,19-cyclolanostanol xylosides, named beesiosides I–IV were isolated. Beesiosides 111 and IV were found also in the rhizomes of S. vaginata. On the basis of chemical and spectral evidence the structure of beesioside III was established as 15α-acetoxy-20ξ₁,24ξ₂-epoxy-9,19-cyclolanostane-3β,12β,16β,25-tetraol-3-O-β-D-xylopyranoside.     

Synthesis, characterization and liquid-phase hydroxylation of phenol with hydrogen peroxide over host (nanopores of zeolite-Y)/guest (oxovanadium(IV) complexes of tetraaza macrocyclic ligands) nanocatalyst

Oxovanadium(IV) tetraaza complexes of [14]aneN₄: 1,5,8,12-tetraaza-2,9-dioxo-4,11-diphenylcyclotetradecane; [16]aneN₄: 1,5,9,13-tetraaza-2,10-dioxo-4,12-diphenylcyclohexadecane; Bzo₂[14]aneN₄: dibenzo-1,5,8,12-tetraaza-2,9-dioxo-4,11-diphenylcyclotetradecane and Bzo₂[16]aneN₄: dibenzo-1,5,9,13-tetraaza-2,10-dioxo-4,12-diphenylcyclohexadecane have been encapsulated in the nanopores of zeolite-Y by a two-step process in the liquid phase: (i) adsorption of [bis(diamine)VO(IV)] (diamine = 1,2-diaminoethane, 1,3-diaminopropane, 1,2-diaminobenzene, 1,3-diaminobenzene); [VO(N-N)₂]²⁺-NaY; in the nanopores of the zeolite-Y and (ii) in situ condensation of the oxovanadium(IV) precursor complex with ethylcinnamate. The new host-guest nanocatalysts were characterized by several techniques: chemical analysis and spectroscopic methods (FT-infrared (FT-IR), ultraviolet-visible (UV-Vis), X-ray diffraction (XRD), nitrogen adsorption and diffuse reflectance spectra (DRS)) technique. The analytical data indicated a composition corresponding to the mononuclear complex of tetraaza ligand. The characterization data showed the absence of extraneous complexes, retention of zeolite crystalline structure and encapsulation in the nanopores. Liquid-phase selective hydroxylation of phenol with H₂O₂ to a mixture of catechol and hydroquinone in CH₃CN have been reported using oxovanadium(IV) tetraaza complexes encapsulated in zeolite-Y as catalysts. All these catalysts are more selective toward catechol formation.     

Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat

The antidiabetic effect of vanadium is a widely accepted phenomenon; some oxovanadium(IV) complexes have been found to normalize high blood glucose levels in both type 1 and type 2 diabetic animals. In light of the future clinical use of these complexes, the relationship among their chemical structures, physicochemical properties, metallokinetics, and antidiabetic activities must be closely investigated. Recently, we found that among bis(3-hydroxypyronato)oxovanadium(IV) [VO(3hp)₂] related complexes, bis(allixinato)oxovanadium(IV) [VO(alx)₂] exhibits a relatively strong hypoglycemic effect in diabetic animals. Next, we examined its metallokinetics in the blood of rats that received five VO(3hp)₂-related complexes by the blood circulation monitoring–electron paramagnetic resonance method. The metallokinetic parameters were obtained from the blood clearance curves based on a two-compartment model; most parameters, such as area under the concentration curve and mean residence time, correlated significantly with the in vitro insulinomimetic activity in terms of 1/IC₅₀ (IC₅₀ is the 50% inhibitory concentration of the complex required for the release of free fatty acids in adipocytes) and the lipophilicity of the complex (log P _com). The oxovanadium(IV) concentration was significantly higher and the species resided longer in the blood of rats that received VO(alx)₂ than in the blood of rats that received VO(3hp)₂ or bis(kojato)oxovanadium(IV); VO(alx)₂ also exhibited higher log P _com and 1/IC₅₀ values. On the basis of these results, we propose that the introduction of lipophilic groups at the C2 and C6 positions of the 3hp ligand is an effective method to enhance the hypoglycemic effect of the complexes, as supported by the observed in vivo exposure and residence in the blood.     

The platinum complexes with histamine: Pt(II)(Hist)Cl2, Pt(II)(Iodo-Hist)Cl2 and Pt(IV)(Hist)2Cl2

The Pt(II) and Pt(IV) complexes with histamine were calculated by using more than 20 DFT functionals and various basis sets. Based on the comparison between the X-ray and theoretical geometrical parameters of the Pt(II)(Hist)Cl₂ complex the MPW1PW91, OPW91 and SVWN5 functionals combined with the 6-311G^∗∗ basis set for non-metallic and SDD (ECP) basis set for platinum were found to yield the most satisfactory agreement. The structure of the Pt(II) complex with iodohistamine important for pharmacy, so far isolated only in minute amounts, was predicted by using the MPW1PW91 functional. Comparison of the theoretical NMR chemical shifts of the Pt(II)(Hist)Cl₂ complex with those found experimentally have shown that the theoretical ¹H and ¹³C NMR chemical shifts are in plausible agreement with the experimental ones, whereas the theoretical ¹⁹⁵Pt chemical shifts fit the experimental values only when the relativistic approach is applied within the ZORA formalism. We confirmed suitability of the three selected functionals for reproduction of the experimental structure of Pt complexes at fourth oxidation state by using the cis- and ions as models. Finally, with the selected theoretical methods, the structures and stabilities of four Pt(IV)(Hist)₂Cl₂ complex isomers were predicted.     

Some carbohydrates of low molecular weight present in Cannabis sativa L

Borate complexes, formed on addition of sodium tetraborate to solutions of carbohydrates in D₂O, can be detected by monitoring changes in the ¹³C magnetic resonance spectra of the parent compounds. In one type of change the chemical shifts remain constant, but broadening of signals of ¹³C atoms in the vicinity of the complex occurs. In the other type, the signals remain sharp, but changes in chemical shift take place. In addition to permitting the detection of borate complexing, it is often possible to ascertain the chemical structures present and to determine quantitatively the relative proportions of complexes and starting materials. A wide variety of polyhydroxy compounds was examined and the formation of complexes of types II, III, and IV assessed. Only two of the 19 compounds examined, 1,2:5,6-di-O-isopropylidene-D-mannitol and cis-inositol, undergo spectral changes on addition of boric acid because of formation of type I and type IV complexes, respectively.     

A New Synthesis of 2-Methyl-6-methyleneocta-2,7-dien-4-ol,A Component of the Pheromane of California Five-spined Ips

A key intermediate, 2-isocyano-3-hydroxybutyrate (III) was isolated from a reaction of isocyanoacetate (I) with acetaldehyde (II) in the presence of Et₃N. It was found that III was readily converted into 2-isocyanocrotonate (V) and 2-isocyano-2-(1′-hydroxyethyl)-3-hydroxybutyrate (VI) which are undesirable compounds for the synthesis of threonine. However, by use of a metal catalyst (e.g. NiCl₂ or PdCl₂), the isocyano-hydroxy compound (III) was selectively converted into 5-methyl-4-alkoxycarbonyl-2-oxazoline (IV) which is an important precursor of threonine. Furthermore, chemical properties of IV were examined; the results suggested that cis-oxazoline was relatively sensitive to acid, base and heat.

On the basis of these results, the reaction of I with II was carried out using Et₃N-PdCl₂ as a catalyst to obtain threo-threonine (85% purity) in a good yield (85%).     

Angiotensin IV protects cardiac reperfusion injury by inhibiting apoptosis and inflammation via AT4R in rats

Angiotensin IV (Ang IV) is formed by aminopeptidase N from Ang III by removing the first N-terminal amino acid. Previously, we reported that Ang III has some cardioprotective effects against global ischemia in Langendorff heart. However, it is not clear whether Ang IV has cardioprotective effects. The aim of the present study was to evaluate the effect of Ang IV on myocardial ischemia-reperfusion (I/R) injury in rats. Before ischemia, male Sprague-Dawley rats received Ang IV (1 mg/kg/day) for 3 days. Anesthetized rats were subjected to 45 min of ischemia by ligation of left anterior descending coronary artery followed by reperfusion and then, sacrificed 1 day or 1 week after reperfusion. Plasma creatine kinase (CK) and lactate dehydrogenase (LDH) concentrations, and infarct size were measured. Quantitative analysis of apoptotic and inflammatory proteins in ventricles were performed using Western blotting. Pretreatment with Ang IV attenuated I/R-induced increases in plasma CK and LDH levels, and infarct size, which were blunted by Ang IV receptor (AT₄R) antagonist and but not by antagonist for AT₁R, AT₂R, or Mas receptor. I/R increased Bax, caspase-3 and caspase-9 protein levels, and decreased Bcl-2 protein level in ventricles, which were blunted by Ang IV. I/R-induced increases in TNF-α, MMP-9, and VCAM-1 protein levels in ventricles were also blunted by Ang IV. Ang IV increased the phosphorylation of Akt and mTOR. These effects were attenuated by co-treatment with AT₄R antagonist or inhibitors of downstream signaling pathway. Myocardial dysfunction after reperfusion was improved by Ang IV. These results suggest that Ang IV has cardioprotective effect against I/R injury by inhibiting apoptosis via AT₄R and PI3K-Akt-mTOR pathway.     

Multiple reactions in vanadyl-V(IV) oxidation by H2O2

Oxidation of vanadyl sulfate by H₂O₂ involves multiple reactions at neutral pH conditions. The primary reaction was found to be oxidation of V(IV) to V(V) using 0.5 equivalent of H₂O₂, based on the loss of blue color and the visible spectrum. The loss of V(IV) and formation V(V) compounds were confirmed by ESR and⁵¹V-NMR spectra, respectively. In the presence of excess H₂O₂ (more than two equivalents), the V(V) was converted into diperoxovanadate, the major end-product of these reactions, identified by changes in absorbance in ultraviolet region and by the specific chemical shift in NMR spectrum. The stoichiometric studies on the H₂O₂ consumed in this reaction support the occurrence of reactions of two-electron oxidation followed by complexing two molecules of H₂O₂. Addition of a variety of compounds—Tris, ethanol, mannitol, benzoate, formate (hydroxyl radical quenching), histidine, imidazole (singlet oxygen quenching), and citrate—stimulated a secondary reaction of oxygen-consumption that also used V(IV) as the reducing source. This reaction requires concomitant oxidation of vanadyl by H₂O₂, favoured at low H₂O₂:V(IV) ratio. Another secondary reaction of oxygen release was found to occur during vanadyl oxidation by H₂O₂ in acidic medium in which the end-product was not diperoxovanadate but appears to be a mixture of VO ₃ ⁺ (–546 ppm), VO³⁺ (–531 ppm) and VO ₂ ⁺ (–512 ppm), as shown by the⁵¹V-NMR spectrum. This reaction also occurred in phosphate-buffered medium but only on second addition of vanadyl. The compounds that stimulated the oxygen-consumption reaction were found to inhibit the oxygen-release reaction. A combination of these reactions occur depending on the proportion of the reactants (vanadyl and H₂O₂), the pH of the medium and the presence of some compounds that affect the secondary reactions.     

The impact of ANG II and IV on INS-1 cells and on blood glucose and plasma insulin

The impact of angiotensin (ANG) for peripheral, global effects is well known. Local ANG systems including that of the insulin-releasing β cell are not well investigated. In insulin-secreting cell line (INS-1), AT₁ and AT₄ receptors for ANG II and IV were demonstrated by Western blots. Only small amounts of ANG II-binding sites of low affinity were observed. ANG II and SARILE displaced binding of ¹²⁵I-ANG II. ANG II and IV as well as their non-degradable analogs SARILE and Nle-ANG IV increased the glucose-induced insulin release in a bell-shaped way; the maximum effect was at ～1?nM. The increase was antagonized by 1 µM losartan or 10 µM divalinal (AT₁ and AT₄ receptor antagonists, respectively). The insulin release was accompanied by a ⁴⁵Ca²⁺ uptake in the case of ANG II and ANG IV. Divalinal abolished the effect of ANG IV and Nle-ANG IV on this parameter. ANG IV reduced the increase in blood glucose during a glucose tolerance test with corresponding, albeit smaller effects on plasma insulin. Using confocal laser scanning microscopy, transfected insulin-regulated aminopeptidase (IRAP) with AT₄ receptors was shown to be accumulated close to the nucleus and the cytosolic membrane, whereas GLUT4 was not detectable. IRAP was inhibited by ANG IV. In conclusion, AT₁ and AT₄ receptors may be involved in diabetic homeostasis. Effects are mediated by insulin release, which is accompanied by an influx of extracellular Ca²⁺. The impact of ANG IV/IRAP agonists may be worth being used as antidiabetics.     

A positively charged surface patch is important for hainantoxin‐IV binding to voltage‐gated sodium channels

Hainantoxin‐IV (HNTX‐IV), isolated from the venom of the spider Ornithoctonus hainana, is a specific antagonist of tetrodotoxin‐sensitive (TTX‐S) voltage‐gated sodium channels in rat dorsal root ganglion (DRG) cells. It adopts an inhibitor cystine knot motif, and structural analysis revealed a positively charged patch consisting of Arg26, Lys27, His28, Arg29 and Lys32 distributed on its molecular surface. Our previous study demonstrated that Lys27 and Arg29 but not Arg26 were critical residues for HNTX‐IV binding to TTX‐S sodium channels. In the present study, we examined the roles of His28 and Lys32 in the interaction of HNTX‐IV with its target. Two mutants, HNTX‐IV‐H28D and HNTX‐IV‐K32A, were generated by solid‐phase chemical synthesis and purified by reverse‐phase HPLC after refolding and oxidation, yielding two compounds of high purity with monoisotopic masses of 3962.66 and 3927.70 Da, respectively, as determined by MALDI‐TOF mass spectrometry. This indicated the presence of six cysteine residues forming three disulfide bonds. Moreover, circular dichroism spectroscopy analysis demonstrated that the substitution of His28 or Lys32 did not affect the overall structure of HNTX‐IV. The inhibitory activity of HNTX‐IV‐H28D and HNTX‐IV‐K32A against TTX‐S sodium channels in rat DRG cells was analyzed by whole‐cell patch‐clamp technique. The IC₅₀ values for the mutants were 0.57 and 5.80 μM (17‐fold and 170‐fold lower than the activity of the native toxin), indicating that His28 and Lys32 may be important for the inhibitory activity of HNTX‐IV. Taken together, our results suggest that the positively charged patch might be the binding site for the interaction of HNTX‐IV with TTX‐S sodium channels. These findings might contribute to the elucidation of the structure and function relationship of HNTX‐IV. Copyright © 2012 European Peptide Society and John Wiley & Sons, Ltd.     

Organopalladium(IV) and platinum(IV) complexes containing the bis(pyrazol-1-yl)borate ligand. Structures of PtMe3{(pz)2BH2}(py) (py=pyridine) and Pt(mq)Me2{(pz)2BH2} (mq=8-methylquinolinyl) and detection of a neutral organopalladium(IV) phosphine complex

Neutral palladium(IV) complexes containing the bis(pyrazol-1-yl)borate ligand, PdMe₃{(pz)₂BH₂}(L) [L=py-d₅ (4), PMe₂Ph (6)], are generated in solution by oxidative addition of iodomethane to [PdMe₂{(pz)₂BH₂}]⁻ at −70 °C followed by addition of L; the Pd(IV) complexes reductively eliminate ethane above 0 °C. Stable Pt(IV) analogues of 4 and 6 have been isolated, and comparison of NMR spectra for Pd(IV) and Pt(IV) species support structural assignments for the unstable Pd(IV) complexes. The complex PtMe₃{(pz)₂BH₂}(py) (1a) has been characterised by X-ray diffraction, together with Pt(mq)Me₂{(pz)₂BH₂} (2) (mq=8-methylquinolinyl); both complexes show a fac-PtC₃ configuration for Pt(IV), and for 2 the PtN distances are ∼0.03 Å shorter than in the isostructural Pd(IV) complex.     

Crystal structure and chemical oxidation of the palladium(II) cyclam complex within the cavity of cucurbit[8]uril

Inclusion compound of a macrocyclic cavitand cucurbit[8]uril (C₄₈H₄₈N₃₂O₁₆, CB[8]) with a square-planar palladium(II) complex of a polyamine ligand cyclam, {[Pd(cyclam)]@CB[8]}Cl₂·16?H₂O (1), was synthesized and characterized by X-ray crystallography, elemental analysis, IR, and electrospray ionization (ESI) mass spectrometry. The complex [Pd(cyclam)]²⁺ undergoes chemical oxidation within the CB[8] cavity leading to the formation of the palladium(IV) inclusion compound {trans-[Pd(cyclam)Cl₂]@CB[8]}Cl₂·14H₂O (2). The Pd(II) and Pd(IV) complexes are completely encapsulated within the CB[8] cavity. The cyclam ring in 1 and 2 adopts the most stable configuration (trans-III (S,S,R,R)).     

Synthesis, characterization and crystal structures of homo- and hetero-substituents containing trans six-coordinate tin(IV) complexes of H2tmtaa (5,14-dihydro-6,8,15,17-tetramethyldibenzo[b,i][1,4,8,11]tetraazacyclotetradecine), and the solid state NMR spectra study of Sn

The reaction of Sn(tmtaa)Cl₂ (H₂tmtaa=5,14-dihydro-6,8,15,17-tetramethyldi-benzo[b,i][1,4,8,11]tetraazacyclotetradecine) and ammonium thiocyanate or sodium azide under a mild condition resulted in trans six-coordinate tmtaa tin(IV) complexes, Sn(tmtaa)X₂ (X=NCS, 1; X=N₃, 2). However, the treatment of Sn(tmtaa)Cl₂ and sodium picrate produced Sn(tmtaa)(Cl)(OC₆H₂ (2,4,6-3NO₂)) (3). Only one chloro atom of Sn(tmtaa)Cl₂ was substituted because of low nucleophilicity of the 2,4,6-trinitrophenolic anion in 3. Furthermore, because of the steric hindrance between the 2,4,6-trinitrophenolic group and the tmtaa ligand, which has a non-planar, saddle-shaped conformation, two chloro atoms cannot be substituted by two 2,4,6-trinitrophenolic groups simultaneously. All complexes were characterized by IR spectra, UV spectra, mass spectra, NMR spectra and elemental analyses, as well as DSC measurements. X-ray crystal structures of 1 and 3 reveal that the complexes retain the characteristic saddle-shaped configuration of H₂tmtaa but have adopted the trans geometry. Solid state ¹¹⁹Sn NMR spectroscopy was used to study the bonding environment in the series of six-coordinate trans Sn(IV) tmtaa complexes. It can be found that the ¹¹⁹Sn chemical shifts of the Sn(IV) tmtaa complexes are almost not influenced by the substituents.     

Electron transfer. Part 165: Oxidations of Ti(II)(aq) with ligated iron(III) and ruthenium(III)

Titanium(II) solutions, prepared by dissolving titanium wire in triflic acid + HF, contain equimolar quantities of Ti(IV). Treatment of such solutions with excess Fe(III) or Ru(III) complexes yield Ti(IV), but reactions with Ti(II) in excess give Ti(III). Oxidations by (NH₃)₅Ru(III) complexes, but not by Fe(III) species, are catalyzed by titanium(IV) and by fluoride. Stoichiometry is unchanged. The observed rate law for the Ru(III)-Ti(II)-Ti(IV) reactions in fluoride media points to competing reaction paths differing by a single F⁻, with both routes involving a Ti(II)-Ti(IV) complex which is activated by deprotonation. It is suggested that coordination of Ti(IV) to Ti^II(aq) minimizes the mismatch of Jahn-Teller distortions which would be expected to lower the Ti(II,III) self-exchange rate.     

Di- and triorganotin(IV) carboxylates derived from triorganotin(IV) iodide with mixed organic groups on tin: Cyclic, hexameric triorganotin(IV) carboxylates

The reaction of ethyldiphenyltin(IV) iodide with silver benzoate in ethanol results in the formation of bis(benzoato)ethylphenyltin(IV), EtPhSn[OC(O)C₆H₅]₂ (1), by the cleavage of a phenyl group bound to tin. The reaction of ethyldiphenyltin(IV) iodide with silver acetate provides acetatoethyldiphenyltin(IV), EtPh₂SnOC(O)CH₃ (2). Similarly, the reaction of diphenylpropyltin(IV) iodide with silver acetate affords acetatodiphenyl-n-propyltin(IV), Ph₂PrSnOC(O)CH₃ (3). These three complexes were characterized by elemental analysis, mass spectrometry, and infrared spectroscopy (IR), as well as ¹H, ¹³C, and ¹¹⁹Sn NMR. The molecular structures of three complexes were also verified by single-crystal X-ray analyses. The X-ray structures show that 1 adopts a skew-trapezoidal bipyramidal structure, while 2 and 3 are rare, cyclic hexameric structures.     

Implications of oxidovanadium(IV) binding to actin

Oxidovanadium(IV), a cationic species (VO²⁺) of vanadium(IV), binds to several proteins, including actin. Upon titration with oxidovanadium(IV), approximately 100% quenching of the intrinsic fluorescence of monomeric actin purified from rabbit skeletal muscle (G-actin) was observed, with a V₅₀ of 131 μM, whereas for the polymerized form of actin (F-actin) 75% of quenching was obtained and a V₅₀ value of 320 μM. Stern-Volmer plots were used to estimate an oxidovanadium(IV)-actin dissociation constant, with K_d of 8.2 μM and 64.1 μM VOSO₄, for G-actin and F-actin, respectively. These studies reveal the presence of a high affinity binding site for oxidovanadium(IV) in actin, producing local conformational changes near the tryptophans most accessible to water in the three-dimensional structure of actin. The actin conformational changes, also confirmed by ¹H NMR, are accompanied by changes in G-actin hydrophobic surface, but not in F-actin. The ¹H NMR spectra of G-actin treated with oxidovanadium(IV) clearly indicates changes in the resonances ascribed to methyl group and aliphatic regions as well as to aromatics and peptide-bond amide region. In parallel, it was verified that oxidovanadium(IV) prevents the G-actin polymerization into F-actin. In the 0-200 μM range, VOSO₄ inhibits 40% of the extent of polymerization with an IC₅₀ of 15.1 μM, whereas 500 μM VOSO₄ totally suppresses actin polymerization. The data strongly suggest that oxidovanadium(IV) binds to actin at specific binding sites preventing actin polymerization. By affecting actin structure and function, oxidovanadium(IV) might be responsible for many cellular effects described for vanadium.     

The tungsten(IV) aqua ion; reduction studies and detection of aquachloro complexes of [W3(μ3-O)(μ2-O)3]4+ by oxygen-17 and tungsten-183 NMR spectroscopy

Oxygen-17 and tungsten-183 NMR studies on solutions of orange tungsten(IV), prepared in 2 M p-toluenesulphonic acid (Hpts) solution via acid catalyzed hydrolysis of potassium hexachlorotungstate(IV) in 2 M Hpts followed by treatment with a single DOWEX 50W X2 cation-exchange column, confirm the formation of the species; [W₃(μ₃-O)(μ₂-O)₃(OH₂)₈Cl]³⁺ as major product in addition to [W₃(μ₃-O)(μ₂-O)₃(OH₂)₉]⁴⁺ under these conditions in a manner not possible by spectrophotometric means. Further characterization of the green W(III,III,IV) mixed-valence reduction product has also been carried out with in addition an estimation of the formal reduction potential for the W(IV)₃/W(III,III,IV) redox couple.     

Evidence for a membrane carbonic anhydrase IV anchored by its C-terminal peptide in normal human pancreatic ductal cells

The high concentration of HCO₃ ^– ions (150 mM) in the human pancreatic ducts raises the question of the membrane proteins responsible for their secretion in addition to the Cl^–/HCO₃ ^– exchanger. In this study, we investigated the expression of carbonic anhydrase IV (CA IV), a possible candidate. Experiments were carried out on specimens of normal human pancreas obtained from brain-dead donors (n=9) as well as on isolated human ductal cells. Two antibodies were generated: CA IV NH₂ antibody directed against the NH₂ terminal of human glycosyl phosphatidylinositol (GPI)-anchored CA IV and CA IV COOH antibody directed against the COOH terminal of the same protein before its association with a GPI in the rough endoplasmic reticulum. A 35-kDa CA IV was detected in the homogenates of human pancreas. Immunocytochemistry demonstrated the expression of CA IV in centroacinar cells and in intercalated, intralobular, and interlobular ductal cells. The immunoreactivity observed with the CA IV COOH antibody was mainly localized on luminal membranes of ductal cells. Treatment of purified plasma membranes with phosphatidylinositol-phospholipase C indicated that the CA IV expressed in pancreatic ducts was not GPI-anchored. Its detection in the same extracts by the CA IV COOH antibody indicated that it was anchored by a hydrophobic segment at the carboxy terminal. Taken together, these results suggest that normal human pancreatic ductal cells express a 35-kDa CA IV anchored in their luminal plasma membrane by a hydrophobic segment of the COOH terminus. In view of its localization and its mode of anchorage in luminal plasma membranes, this CA IV may participate in the maintenance of luminal pH.The first two authors have contributed equally to this work